Health Advances Blog

Reflections on Healthcare & Life Sciences Innovation

Skip to content
Menu
  • Home
  • Website
  • About
  • by healthadvances
  • Posted on May 20, 2015April 11, 2016

Insights from the T1D Exchange Annual Meeting

Read More
  • by healthadvances
  • Posted on May 7, 2015April 11, 2016

Immunotherapy & Combination Therapy Hot Topics at the AACR 2015

Read More
  • by healthadvances
  • Posted on May 4, 2015April 11, 2016

The Helmsley Trust Awards $8.7M funding for T1D Research

Read More
  • by healthadvances
  • Posted on April 27, 2015November 14, 2017

New white paper! “Big Bets on Value-Based Care”

Read More

Posts navigation

Previous Page Page 1 … Page 5 Page 6

Recent Posts

  • PCSK9 Inhibitors’ Battle for Reimbursement: Germany’s Decision and Implications in Other Countries April 10, 2018
  • Three Models for Population Health Technology April 4, 2018
  • Rare Disease Prevalence and Orphan Drug Pricing in Europe April 3, 2018
  • Highlights of the European Society for Medical Oncology (ESMO) Immuno-Oncology Congress March 22, 2018
  • Seattle’s Journey to the Summit of Cancer Commercialization March 14, 2018

Social

  • View facebook.com/healthadvances’s profile on Facebook
  • View @healthadvances’s profile on Twitter
  • View linkedin.com/company/health-advances’s profile on LinkedIn

Follow me on Twitter

My Tweets
Blog at WordPress.com.